Australian cancer drugs maker Mayne Pharma Ltd. has received an over A$2 billion ($1.5 billion) takeover approach from an international rival, the Australian Financial Review newspaper reported on Wednesday.
Hospira? Novartis??
Come on guys/gals drop Insider an email......... you know you want to!
Reuters
No comments:
Post a Comment